Skip to content

Clinical trials

Phase 1 Hepatitis B, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 1 Country / region: New Zealand Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20141
20151
20164
20173
20183
20204
20213
20224
20235
20245
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated9
Recruiting3
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Assembly Biosciences6
Aligos Therapeutics4
Alios Biopharma Inc.2
AusperBio Therapeutics Inc.2
Gilead Sciences2
Janssen Research & Development, LLC2
Alnylam Pharmaceuticals1
Arbutus Biopharma Corporation1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic38
Hepatitis B13
DNA Virus Infections1
Hepatitis1
Hepatitis, Chronic1
Liver Diseases1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.